| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/28/1997 | US5597825 Aggregation inhibitors |
| 01/28/1997 | US5597804 N-sulfonylarginine keto-amide compounds |
| 01/23/1997 | WO1997002285A1 Macrolides |
| 01/23/1997 | WO1997002284A1 New thrombin inhibitors, their preparation and use |
| 01/23/1997 | WO1997002051A2 Cascade polymer complexes |
| 01/23/1997 | WO1996040743A3 Inhibitors of factor xa |
| 01/23/1997 | CA2225959A1 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 01/23/1997 | CA2224715A1 Macrolides |
| 01/22/1997 | EP0754702A2 Cyclopentane-beta-amino acid-tripeptides |
| 01/22/1997 | EP0754678A2 Improvement of physiological tolerance of pharmaceutical active beta-amino acids |
| 01/22/1997 | EP0754302A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 01/22/1997 | EP0528858B1 Inhibitors of dipeptidyl-aminopeptidase type iv |
| 01/22/1997 | CN1141002A Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 01/22/1997 | CN1140709A Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/21/1997 | US5596000 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 01/21/1997 | US5595990 Treatment of cardiovascular disorders |
| 01/21/1997 | US5595877 Methods of producing nucleic acid ligands |
| 01/20/1997 | CA2181308A1 Improving the tolerability of pharmaceutically active beta-amino acids |
| 01/16/1997 | WO1997001579A2 Somatostatin peptides |
| 01/16/1997 | WO1997001576A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 01/16/1997 | WO1997001338A1 Pyridinone-thrombin inhibitors |
| 01/16/1997 | WO1996034113A3 Methods for the identification of farnesyltransferase inhibitors |
| 01/16/1997 | CA2224437A1 Pyridinone-thrombin inhibitors |
| 01/16/1997 | CA2197861A1 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 01/15/1997 | EP0753526A1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient |
| 01/15/1997 | EP0753059A1 Peptide production as fusion protein in transgenic mammal milk |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0753003A1 Aziridine derivatives, their production and use |
| 01/15/1997 | EP0752987A1 Pyrimidinyl derivatives as interleukin inhibitors |
| 01/15/1997 | EP0752873A1 Labelled peptide compounds |
| 01/15/1997 | EP0539484B1 Method for preparing sulphonylpristinamycin iib |
| 01/15/1997 | CN1140455A Diastereomeric pure trifluoromethyl ketone peptide derivs. as inhibitors of human leukocyte elastase |
| 01/15/1997 | CN1140454A Novel mercaptoacetylamido-1,3,4,5-tetrahydro-benzo|c¨ azepin-3-one disulfide derivs. useful as inhibitors of enkephalinase and ACE |
| 01/14/1997 | US5594151 Phenylboronic acid complexing reagents derived from aminosalicylic acid |
| 01/14/1997 | US5594106 Inhibitors of TNF-α secretion |
| 01/14/1997 | US5593967 Cholecystokinin antagonists, their preparation and therapeutic use |
| 01/14/1997 | US5593642 Containment of solid support within a gas dispersion tube |
| 01/09/1997 | WO1997000894A1 Compounds with growth hormone releasing properties |
| 01/09/1997 | WO1997000890A1 Peptide that inhibits blood triglyceride level rise and blood triglyceride level rise inhibitor containing said peptide as active ingredient |
| 01/09/1997 | WO1997000889A1 Peptides binding to low-density lipoproteins |
| 01/09/1997 | WO1997000886A1 Obesity protein intermediates and their preparation and use |
| 01/09/1997 | DE19525924A1 Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel Cascade polymer complexes, process for their preparation and pharmaceutical compositions containing them |
| 01/09/1997 | CA2224867A1 Obesity protein intermediates and their preparation and use |
| 01/09/1997 | CA2224434A1 Compounds with growth hormone releasing properties |
| 01/08/1997 | EP0752425A2 Peptide ligands for the constant region of immunoglobulins |
| 01/08/1997 | EP0751961A1 Eating suppressant peptides |
| 01/08/1997 | EP0751960A1 Synthetic inverso or retro-inverso t-cell epitopes |
| 01/08/1997 | EP0751783A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives |
| 01/08/1997 | EP0751779A1 Selectively cleavable linkers based on iminodiacetic acid ester bonds |
| 01/08/1997 | EP0751768A1 Anti-viral and anti-cancer agents |
| 01/08/1997 | EP0579789B1 Method of separating a peptide from a resin |
| 01/08/1997 | EP0558657B1 Retroviral protease inhibitors |
| 01/08/1997 | EP0386044B1 Hypoglycaemic peptides |
| 01/07/1997 | US5591891 N-[Mercaptoacyl (amino acid or peptide ) ] compounds and S-lipophiIic aliphatic carbonyl derivatives thereof as antihypertensives |
| 01/07/1997 | US5591886 Process for the crystallizing L-α-aspartyl-L-phenylalanine methyl ester from the solution |
| 01/07/1997 | US5591884 Dopamine agonists |
| 01/07/1997 | US5591860 Retroviral protease inhibiting compounds |
| 01/07/1997 | US5591739 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
| 01/07/1997 | US5591728 New phosphonic acid compounds |
| 01/07/1997 | US5591711 Lysine-glycine-histidine tripeptide, fibroblast proliferation |
| 01/07/1997 | US5591614 Process for the enzymatic preparation of macrolactone |
| 01/07/1997 | US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor |
| 01/07/1997 | US5591591 Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore |
| 01/07/1997 | CA2004606C Process for preparing optically active 2-oxoimidazolidine derivatives |
| 01/03/1997 | WO1997000268A1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 01/03/1997 | WO1997000241A1 New cationic and polycationic amphiphiles, reactives containing the same and their use |
| 01/03/1997 | WO1997000071A1 Androgenic directed compositions |
| 01/03/1997 | CA2225484A1 Androgenic directed compositions |
| 01/03/1997 | CA2224566A1 New cationic and polycationic amphiphiles, reagents containing them and their use |
| 01/02/1997 | EP0751146A1 Crystallization of alpha-L-aspartyl-l-phenylalanine methyl ester from aqueous solution |
| 01/02/1997 | EP0750631A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 01/02/1997 | EP0750610A1 Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis |
| 01/02/1997 | EP0750609A1 Isoprenyl transferase inhibitors |
| 01/02/1997 | EP0750508A1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS |
| 01/02/1997 | EP0750507A1 PROTEASOME REGULATION OF NF-$g(k)B ACTIVITY |
| 01/02/1997 | EP0662145B1 Process for the selective increase of production of antibiotic ge 2270 factor a |
| 01/01/1997 | CN1139427A Malarial aspartic protease inhibitors |
| 01/01/1997 | CN1138983A Preparation of drug composition |
| 12/31/1996 | US5589579 Gene sequence and probe for a marker of non-small cell lung carinoma |
| 12/31/1996 | US5589460 Modification of melanotrophic release inhibiting factor |
| 12/31/1996 | US5589459 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
| 12/31/1996 | US5589458 Compounds that inhibit T cell proliferation and methods for using the same |
| 12/31/1996 | CA2180207A1 Crystallization of .alpha.-l-aspartyl-l-phenylalanine methyl ester from aqueous solution |
| 12/27/1996 | WO1996041830A1 Cascade polymers with iodine-containing aromatic compounds |
| 12/27/1996 | WO1996041640A1 Bradykinin analogs as selective thrombin inhibitors |
| 12/27/1996 | WO1996041638A1 Calpain inhibitors for the treatment of neurodegenerative diseases |
| 12/27/1996 | WO1996031525A3 Inhibitors of farnesyl-protein transferase |
| 12/27/1996 | WO1996030395A3 Cysteine protease inhibitor |
| 12/27/1996 | EP0749978A1 Method of separating and purifying trh analogs and process for producing solvates of trh analogs |
| 12/27/1996 | EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof |
| 12/27/1996 | EP0749316A1 Antithrombotic agents |
| 12/27/1996 | CA2224721A1 Calpain inhibitors for the treatment of neurodegenerative diseases |
| 12/24/1996 | US5587514 Reacting enolate of alpha-n,n-di-protected-aminoalkyl methyl ketone with alpha-leaving group acetate or acetamide |
| 12/24/1996 | US5587475 Derivatized virginiamycin M1 |
| 12/24/1996 | US5587388 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof |
| 12/24/1996 | US5587375 Azepinone compounds useful in the inhibition of ACE and NEP |
| 12/19/1996 | WO1996041172A1 Functional surrogates of analytes of interest and methods of obtaining and using same |
| 12/19/1996 | WO1996040752A1 Novel dolastatin derivatives, their preparation and use |
| 12/19/1996 | WO1996040751A1 Novel dolastatin derivatives, their preparation and use |
| 12/19/1996 | WO1996040748A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders |